Imagine finally getting your psoriasis under control, your skin completely clear. The next, nagging thought is: how long will this last? A new study offers a glimpse of an answer for one specific treatment. Researchers tracked over 500 patients with psoriasis who were treated with a drug called bimekizumab. They focused on those who had achieved complete skin clearance after 16 weeks of treatment and then continued on the medication. After four years of follow-up, about 73% of those patients were still maintaining that complete clearance. That's a notable finding for a condition where flare-ups are common. The study also looked at what was happening beneath the skin. After just eight weeks of treatment, samples showed the drug was reversing key molecular signals linked to the overactive immune cells that drive psoriasis. This suggests the treatment might be helping to reset the skin's biology. It's important to understand what this data does and doesn't tell us. These long-term results come from an extension phase where everyone knew they were getting the drug, which can sometimes influence outcomes. The molecular findings are from separate analyses, not the same patients followed for four years. And while the association is intriguing, it doesn't prove the molecular changes directly cause the long-lasting results. The study also didn't report on safety over this period or compare bimekizumab to other treatments.
Can psoriasis treatment keep skin clear for years? New data suggests it might.
Photo by Sasun Bughdaryan / Unsplash
What this means for you:
For some, psoriasis drug bimekizumab maintained clear skin for 4 years in a long-term study. More on Psoriasis
Systematic review shows regional differences in HS comorbidity prevalence across North America, Europe, and Asia. Regional differences in health risks for hidradenitis suppurativa patients
· May 1, 2026
Narrative review discusses ginsenosides for skin conditions including psoriasis and dermatitis with noted evidence gaps. Review of ginsenosides for skin conditions shows weak evidence and low absorption.
Frontiers · Apr 24, 2026
Herring roe oil reduces inflammatory biomarkers in mild-to-moderate psoriasis Herring roe oil may lower inflammation in psoriasis
medRxiv · Apr 23, 2026
Secukinumab improves skin response in Chinese patients with psoriatic arthritis Secukinumab linked to skin improvement in Chinese psoriatic arthritis patients
Frontiers · Apr 23, 2026